PSTV (STOCKS)
PLUS THERAPEUTICS, Inc. Common Stock
$5.260000
+0.460000 (+9.58%)
Prev close: $4.800000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Marc H. Hedrick
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $37.64M
- Employees
- 21
- P/E (TTM)
- -0.17
- P/B (TTM)
- 6.66
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $5.21M |
| Benefits Costs and Expenses | $27.60M |
| Costs And Expenses | $27.60M |
| Nonoperating Income/Loss | -$7.09M |
| Operating Expenses | $20.51M |
| Research and Development | $8.38M |
| Other Operating Expenses | $12.13M |
| Operating Income/Loss | -$15.30M |
| Income/Loss From Continuing Operations After Tax | -$22.39M |
| Income/Loss From Continuing Operations Before Tax | -$22.39M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$22.39M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$22.39M |
| Net Income/Loss Available To Common Stockholders, Basic | -$22.39M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.29 |
| Diluted Earnings Per Share | -$0.29 |
| Basic Average Shares | 77,804,612 |
| Diluted Average Shares | 77,804,612 |
| Assets | $16.33M |
| Current Assets | $15.17M |
| Cash | $13.10M |
| Other Current Assets | $2.07M |
| Noncurrent Assets | $1.16M |
| Fixed Assets | $257.00K |
| Other Non-current Assets | $898.00K |
| Liabilities | $12.33M |
| Current Liabilities | $12.31M |
| Accounts Payable | $3.28M |
| Other Current Liabilities | $9.04M |
| Noncurrent Liabilities | $15.00K |
| Equity | $4.00M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $4.00M |
| Liabilities And Equity | $16.33M |
| Net Cash Flow From Operating Activities | -$20.78M |
| Net Cash Flow From Operating Activities, Continuing | -$20.78M |
| Net Cash Flow From Investing Activities | -$854.00K |
| Net Cash Flow From Investing Activities, Continuing | -$854.00K |
| Net Cash Flow From Financing Activities | $30.31M |
| Net Cash Flow From Financing Activities, Continuing | $30.31M |
| Net Cash Flow | $8.68M |
| Net Cash Flow, Continuing | $8.68M |
| Comprehensive Income/Loss | -$22.39M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$22.39M |
| Other Comprehensive Income/Loss | $0.00 |